MGO One Seven’s Amneal Pharmaceuticals AMRX Stock Holding History

MGO One Seven’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-975	Closed	-$13K	–	471
2018 Q4	$13K	Buy	+975	New	+$17.6K	0.01%	1048

Other funds holding AMRX

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

TCW Group Los Angeles, California $14.9B AUM 46.29% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

MGO One Seven's AMRX Position: Q1 2019 in Review

MGO One Seven sold out of Amneal Pharmaceuticals (AMRX) in Q1 2019, closing a stake of 975 shares — an estimated $13K sold.

MGO One Seven first reported a position in AMRX in Q4 2018 and held it in 1 quarter. The position peaked at $13K in Q4 2018. 164 funds tracked by Wall St. Rank hold AMRX as of Q1 2019.

MGO One Seven reported no remaining Amneal Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
MGO One Seven sold 975 Amneal Pharmaceuticals shares in Q1 2019, an estimated $13K.
MGO One Seven first reported a position in Amneal Pharmaceuticals in Q4 2018 and held it in 1 quarter.
MGO One Seven's Amneal Pharmaceuticals position peaked at $13K in Q4 2018.
164 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q1 2019.

Based on MGO One Seven's 13F filing for Q1 2019, filed 9 Apr 2019.